PRESS RELEASE PRESS RELEASE PRESS RELEASE
2019 Financial Calendar
Paris, September 9, 2019, 5:45 pm CEST - NEOVACS (Euronext Growth Paris: ALNEV) leader in active immunotherapy for the treatment of auto-immune and inflammatory diseases publishes an updated 2019 financial calendar today.
Financial announcements will be published before the market opening. The expected dates are preliminary so may be subject to change.
- 2019 First Half Results October 2, 2019
- 2019 Annual Results March 29, 2020
- Annual General Meeting 1st call Date to be confirmed
About Neovacs
Listed on Euronext Growth since 2010, Neovacs is today a leading biotechnology company focused on an active immunotherapy technology platform
Contacts
| Néovacs Corporate Communication & Investor Relations Charlène Masson +33 1 53 10 93 00 cmasson@neovacs.com (mailto:ntrepo@neovacs.com) | Press Relations - NewCap Annie-Florence Loyer +33 (0)6 88 20 35 59 +33 (0)1 44 71 00 12 afloyer@newcap.fr (mailto:afloyer@newcap.fr) Léa Jacquin Tel : +33(0)1 44 71 20 41 ljacquin@newcap.fr | Orphéon Finance Financial Communication and Investor Relations James Palmer +33 7 60 92 77 74 j.palmer@orpheonfinance.com (mailto:j.palmer@orpheonfinance.com) |
Attachment
- Press Release (https://ml-eu.globenewswire.com/Resource/Download/1deac5b1-4bfd-43c2-98ea-3fd6c24dd54d)
© 2019 GlobeNewswire (Europe)
